Patterns of multiple primaries in fortyfour cancer patients: a single-center clinical experience

被引:0
|
作者
Duymus, Mehmet Esat [1 ]
Koseci, Tolga [2 ]
Serindere, Mehmet [3 ]
Ceylan, Meral [2 ]
Bulgurcu, Abdullah [4 ]
Ipci, Ozlem [5 ]
Karadeniz, Cemile [2 ]
Bag, Yusuf Murat [6 ]
Kaya, Dilsa Mizrak [2 ]
机构
[1] Hatay Educ & Res Hosp, Dept Surg Oncol, Antakya, Turkiye
[2] Hatay Educ & Res Hosp, Dept Med Oncol, Antakya, Turkiye
[3] Hatay Educ & Res Hosp, Dept Radiol, Antakya, Turkiye
[4] Hatay Educ & Res Hosp, Dept Gen Surg, Antakya, Turkiye
[5] Hatay Educ & Res Hosp, Dept Pathol, Antakya, Turkiye
[6] Van Training & Researcher Hosp, Dept Gastrointestinal Surg, Van, Turkiye
来源
ONCOLOGY IN CLINICAL PRACTICE | 2023年 / 19卷 / 01期
关键词
carcinoma; invasive cancer; multiple primaries; pattern; survival; 1; 28-33; STATISTICS; RISK;
D O I
10.5603/OCP.2022.0047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. Multiple primaries are defined as the existence of more than one synchronous or metachronous cancer type in the same individual. Due to a longer follow-up time after a primary cancer diagnosis, the likelihood of detection of a second primary is also increased. We report on patterns of multiple primaries in a cohort of cancer patients from a single institution.Material and methods. We identified 44 patients with multiple primaries that were diagnosed, treated, and followed up between March 2011 and January 2022 from our prospectively maintained database at the Hatay Education and Research Hospital Cancer Unit.Results. The median follow-up time was 60 months (range; 3-103). The median time between the diagnosis of the first primary and the second primary was 29 months (range; 0-94). The median OS was 76 months (95% Cl 26.6-125.4) from the first diagnosis and 27 months (95% Cl 0.65-53.4) from the diagnosis of the second primary for the entire cohort. The first diagnosed tumor was localized in the gastrointestinal system in 43.2% of patients and 65.9% of all tumors were adenocarcinoma. The first diagnosed cancer was at an early stage (Stages I and II) in 63.6% of patients. At the staging evaluation of the second primary, 54.5% of patients were found to be in the early stage (Stages I and II) and 45.5% were found to be in the late stage (Stages III and IV).Conclusions. Our study is important as this is the largest cohort study about practical implications of managing multiple primaries. The risk of second and further primaries should be kept in mind in the active follow-up Introduction and surveillance of cancer patients .
引用
收藏
页码:28 / 33
页数:6
相关论文
共 50 条
  • [41] Clinicopathological features and outcomes of patients with gastric cancer: A single-center experience
    Selcukbiricik, Fatih
    Buyukunal, Evin
    Tural, Deniz
    Ozguroglu, Mustafa
    Demirelli, Fuat
    Serdengecti, Suheyla
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (14) : 2154 - 2161
  • [42] Autologous retransplantation for patients with recurrent multiple myeloma A Single-Center Experience with 200 Patients
    Sellner, Leopold
    Heiss, Christiane
    Benner, Axel
    Raab, Marc S.
    Hillengass, Jens
    Hose, Dirk
    Lehners, Nicola
    Egerer, Gerlinde
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Neben, Kai
    CANCER, 2013, 119 (13) : 2438 - 2446
  • [43] European single-center experience on 356 operated patients for gastric cancer
    Garofalo, Alfredo
    Carboni, Fabio
    Federici, Orietta
    Giofre, Manuel
    Balla, Andrea
    Valle, Mario
    Ursi, Pietro
    ANNALI ITALIANI DI CHIRURGIA, 2020, 91 (02) : 137 - 143
  • [44] A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience
    Madabhavi, Irappa
    Patel, Apurva
    Sarkar, Malay
    Anand, Asha
    Panchal, Harsha
    Parikh, Sonia
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2017, 11
  • [45] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
    Sbragia, E.
    Olobardi, D.
    Giovanni, N.
    Lapucci, C.
    Boffa, G.
    Capello, E.
    Cellerino, M.
    Laroni, A.
    Sticchi, L.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 648 - 649
  • [46] Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
    Skelton, William P.
    Ali, Azka
    Skelton, Michelle N.
    Federico, Roland
    Bosse, Raphael
    Thu-Cuc Nguyen
    Dang, Long H.
    Bishnoi, Rohit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (04)
  • [47] Multiple Presentations of LRBA Deficiency: a Single-Center Experience
    Bal, Sevgi Kostel
    Haskologlu, Sule
    Serwas, Nina K.
    Islamoglu, Candan
    Aytekin, Caner
    Kendirli, Tanil
    Kuloglu, Zarife
    Yavuz, Gulsan
    Dalgic, Buket
    Siklar, Zeynep
    Kansu, Aydan
    Ensari, Arzu
    Boztug, Kaan
    Dogu, Figen
    Ikinciogullari, Aydan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (08) : 790 - 800
  • [48] Lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate: A single-center experience
    Dinoto, Alessandro
    Sartori, Arianna
    Cheli, Marta
    Pasquin, Fulvio
    Baldini, Sara
    Bratina, Alessio
    Bosco, Antonio
    Manganotti, Paolo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [49] Multiple Presentations of LRBA Deficiency: a Single-Center Experience
    Sevgi Kostel Bal
    Sule Haskologlu
    Nina K. Serwas
    Candan Islamoglu
    Caner Aytekin
    Tanil Kendirli
    Zarife Kuloglu
    Gulsan Yavuz
    Buket Dalgic
    Zeynep Siklar
    Aydan Kansu
    Arzu Ensari
    Kaan Boztug
    Figen Dogu
    Aydan Ikinciogullari
    Journal of Clinical Immunology, 2017, 37 : 790 - 800
  • [50] Mitoxantrone in the Treatment of Multiple Sclerosis: a Single-Center Experience
    Taskapilioglu, Ozlem
    Sener, Deniz Kamaci
    Turan, Asli Bahar
    Yurtogullari, Sukran
    Tutuncu, Ahmet
    Gullulu, Sumeyye
    Ocakoglu, Gokhan
    Turan, Omer Faruk
    TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (02) : 62 - 66